Syros Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Syros Pharmaceuticals, Inc. has filed 682 SEC EDGAR filings since 22 Aug 2012

SEC filing history

Showing 51-75 of 682 matching filings.

Per page
25
Current page
3
144 File 001-37813

144 filing

Filing date
25 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Nov 2024
Reporting date
19 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Nov 2024
Reporting date
18 Nov 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37813

144 filing

Filing date
19 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37813

144 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37813

144 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37813

144 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37813

144 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37813

144 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-37813

144 filing

Filing date
18 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-89552

SC 13G/A

Filing date
12 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Nov 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Nov 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Nov 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Nov 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
04 Nov 2024
Reporting date
31 Oct 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .